Laird Norton Wetherby Wealth Management’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,907
| Closed | -$221K | – | 926 |
|
|
2022
Q3 | $221K | Sell |
2,907
-36
| -1% | -$2.74K | 0.02% | 774 |
|
|
2022
Q2 | $205K | Buy |
2,943
+246
| +9% | +$17.1K | 0.01% | 805 |
|
|
2022
Q1 | $223K | Sell |
2,697
-190
| -7% | -$15.7K | 0.01% | 818 |
|
|
2021
Q4 | $217K | Buy |
2,887
+172
| +6% | +$12.9K | 0.01% | 823 |
|
|
2021
Q3 | $315K | Sell |
2,715
-103
| -4% | -$12K | 0.02% | 679 |
|
|
2021
Q2 | $625K | Buy |
2,818
+366
| +15% | +$81.2K | 0.04% | 431 |
|
|
2021
Q1 | $324K | Sell |
2,452
-194
| -7% | -$25.6K | 0.02% | 581 |
|
|
2020
Q4 | $458K | Buy |
2,646
+388
| +17% | +$67.2K | 0.03% | 484 |
|
|
2020
Q3 | $251K | Buy |
+2,258
| New | +$251K | 0.02% | 573 |
|